期刊文献+

三级医院心力衰竭门诊管理方案对患者预后的影响 被引量:31

Effects of integrated disease management program on the outcome of patients with heart failure
原文传递
导出
摘要 目的 探索结合心力衰竭(心衰)门诊、心衰教育和电话随访的心衰疾病管理方案的可行性,观察该方案对患者预后的影响.方法 入选住院的心衰患者145例,男91例,女54例,平均年龄(69.6±11.3)岁,纽约心功能分级(NYHA分级)Ⅱ-Ⅳ级,左室射血分数(LVEF)≤45%或LVEF〉45%时N末端B型利钠肽原〉1500 ns/L.根据个人意愿分为非疾病管理组和疾病管理组,疾病管理组进行一系列的干预措施,包括开展心衰教育、电话随访、定期心衰门诊就诊.于分组后10~12个月比较两组患者的结果.结果 基线时两组患者临床特征、LVEF及药物使用率、达标率差异无统计学意义.随访时,疾病管理组NYHA分级为(1.4±0.5)级,LVEF为40%±8%;非疾病管理组NYHA分级为(3.2±0.5)级,LVEF为31%±6%.疾病管理组自行监测体重、血压和脉搏的比例均显著高于非疾病管理组(P〈0.05).在收缩性心衰患者中,疾病管理组40%患者的β受体阻滞剂达标剂量显著高于非疾病管理组的11%(P〈0.05);疾病管理组66%患者的血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体拮抗剂达标剂量高于非疾病管理组的37%,但差异无统计学意义(P=0.09).非疾病管理组心血管病事件率为91.5%,疾病管理组心血管事件率为27.0%,两者差异有统计学意义(P〈0.05).结论 结合心衰门诊、心衰教育和电话随访的心衰疾病管理方案可显著改善心衰患者的治疗依从性,增加有效药物的治疗剂量,改善患者的心功能并降低心血管病事件率. Objective To investigate the feasibility and efficacy on the outcome of patients with heart failure of integrated disease management program with heart failure clinic, patient education and telephone follow-up. Methods A total of 145 hospitalized patients with chronic heart failure and LVEF≤ 45% or patients with LVEF 〉45% and NT-proBNP 〉 1500 ng/L were divided into conventional group (re = 71) and interventional group (n =74). Patients were followed for 10 to 12 months. Results Baseline clinical characteristics, LVEF and dose of evidence-based medicine were similar between the 2 groups. During follow-up, the NYHA functional class was higher in conventional group than interventional group (3.2±0.5 vs 1.4±0.5, P 〈0.05) , and the LVEF deteriorated in the conventional group and improved from 34% to 40% in the interventional group. The proportions of self-monitoring of weight, blood pressure and pulse rate in the interventional group were significantly higher than those of conventional group (P 〈 0. 05). Among patients with systolic heart failure, 40% patients in the interventional group and 11 % patients in the conventional group achieved the target doses of β-blockers (P〈0.05). Cardiovascular event rate of conventional group and interventional group is 91. 5% and 27. 0% respectively ( P 〈 0. 05 ). Conclusion Integrated disease management program with heart failure clinic, patient education and telephone follow-up can improve patient compliance to heart failure treatment, improve cardiac function and reduce cardiovascular event rate.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2010年第7期592-596,共5页 Chinese Journal of Cardiology
关键词 心力衰竭 充血性 疾病管理 预后 生活质量 Heart failure, congestive Disease management Prognosis Quality of life
  • 相关文献

参考文献15

  • 1Akosah KO,Schaper AM,Haus LM,et al.Improving outcomes in heart failure in the community:long-term survival benefit of a disease-management program.Chest,2005,127:2042-2048.
  • 2Hebert PL,Sisk JE,Wang JJ.et al.Cost-effectiveness of nurseled disease management for heart failure in an ethnically diverse urban community.Ann Intern Med,2008,149:540-548.
  • 3庞海燕,王林,马金萍,陈康寅,陈树涛,李广平,黄体钢.β-受体阻滞剂在慢性心力衰竭药物治疗中应用现状[J].中国慢性病预防与控制,2007,15(5):442-444. 被引量:30
  • 4Hunt SA,Abraham WT,Chin MH,et al.2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults; a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guideline; developed in collaboration with the international Society for Heart and Lung Transplantation.Circulation,2009,119; e391-e479.
  • 5Jaarsma T,van der Wal MH,Lesman-Leegte I,et al.Effect of moderate or intensive disease management program on outcome in patients with heart failure coordinating study evaluating outcomes of advising and counseling in heart failure (COACH).Arch Intern Med,2008,168:316-324.
  • 6Nucifora G,Albanese M,De Biaggio P,et al.Lack of improvement of clinical outcomes by a low-cost,hospital-based heart failure management programme.J Cardiovasc Med,2006,7:614-622.
  • 7Smith B,Forkner E,Zaslow B,et al.Disease management produces limited quality-of-life improvements in patients with congestive heart failure; evidence from a randomized trial in community-dwelling patients.Am J Manage Care,2005,11:701-713.
  • 8Nguyen V,Ducharme A,White M,et al.Lack of long-term benefits of a 6-month heart failure disease management program.J Card Fail,2006,13:287-293.
  • 9Holland R,Brooksby I,Lenaghan E,et al.Effectiveness of visits from community pharmacists for patients with heart failure:Heart Med randomised controlled trial.BMJ,2007,334:1066-1067.
  • 10Ledwidge M,Ryan E,O'Loughlin C,et al.Heart failure care in a hospital unit; a comparison of standard 3-month and extended 6-month programs.Eur J Heart Fail,2005,7:385-391.

二级参考文献12

  • 1王林,马金萍,党群,陈康寅,李永健,李喜元,陈树涛,丛洪良,李广平,黄体钢.老年慢性心力衰竭住院患者2656例的回顾性分析[J].中华老年医学杂志,2006,25(8):565-569. 被引量:40
  • 2Andrews R, Cowley AJ. Clinical and economic factors in the treatment of congestive heart failure[J]. Pharmacoeconomics, 1995, 7:119-121.
  • 3CIBIS- Ⅱ Invesitigators and Committees. The cardiac insufficiency bisoporolol study Ⅱ(CIBIS- Ⅱ)[J]. Lancet, 1999, 353: 9-13.
  • 4MERIT-HF Study Group. Effect of metoprolo CR/XL in chronic heart failure : metoprolo CR/XL randomised intervention trial in congestive heart failure (MERIT-HF)[J]. Lancet, 1999, 353:2001-2007
  • 5Murphy N F, Simpson CR, Mcalister FA, et al. National survety of the prevalence, incidence, primary care burden, and treatment of heart failure in Scotland[J]. Heart, 2004, 90:1129-1136.
  • 6Friedrich M, Fruhwald R, Peter R, et al. Austrian survey of treating heart failure-AUSTRIA [J]. Eur J Heart Fail, 2004, 6: 1-7.
  • 7Cleland J, Sqedberg K, Follath F, et al. The euroHeart failure survey programme-a survey on the quality fo care among patients with heart failure in Europe [J]. Eur Heart J, 2003, 24: 464-475.
  • 8Rywik TM, Rywik SL, Korewicki J, et al. A survey of outpatient management of elderly heart failure patients in Poland-treatment patterns[J]. Int J Cardiol, 2004, 95: 177-184.
  • 9Soon SR, Yong R, Chew ZH, et al. Pilot survey of the diagnosis and management of heart failure in primary care: a singaporean perspective[J]. Ann Acad Med Singapore, 2004, 33: 413-418.
  • 10Norwegian Multicenter Study Group. Timolol induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction[J]. N Engl J Med, 1981, 304:1115-1122.

共引文献29

同被引文献261

引证文献31

二级引证文献197

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部